BT Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$393K Sell
2,213
-262
-11% -$46.7K 0.11% 46
2022
Q1
$439K Sell
2,475
-80
-3% -$13.6K 0.11% 43
2021
Q4
$437K Buy
2,555
+195
+8% +$31.9K 0.12% 42
2021
Q3
$381K Buy
2,360
+202
+9% +$34.5K 0.12% 37
2021
Q2
$356K Sell
2,158
-10,275
-83% -$1.7M 0.11% 40
2021
Q1
$2.04M Sell
12,433
-176
-1% -$28.5K 0.68% 18
2020
Q4
$1.98M Sell
12,609
-116
-0.9% -$17.1K 0.74% 16
2020
Q3
$1.9M Buy
12,725
+2
+0% +$296 0.82% 16
2020
Q2
$1.79M Buy
12,723
+2
+0% +$291 0.91% 13
2020
Q1
$1.67M Sell
12,721
-534
-4% -$75.8K 0.95% 11
2019
Q4
$1.93M Buy
13,255
+1,282
+11% +$174K 0.98% 16
2019
Q3
$1.55M Sell
11,973
-7
-0.1% -$922 0.86% 18
2019
Q2
$1.56M Buy
11,980
+11
+0.1% +$1.52K 0.9% 18
2019
Q1
$1.67M Sell
11,969
-2,733
-19% -$366K 0.99% 16
2018
Q4
$1.98M Buy
+14,702
New +$2.05M 0.85% 16

Other funds holding JNJ

BT Wealth Management's JNJ Position: Q2 2022 in Review

BT Wealth Management reduced its Johnson & Johnson (JNJ) stake by 11% in Q2 2022, selling an estimated $46.7K and leaving 2,213 shares worth $393K. The position accounts for 0.11% of the portfolio, ranked #46.

BT Wealth Management first reported a position in JNJ in Q4 2018 and has held it in 15 quarters since. The position peaked at $2.04M in Q1 2021. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • BT Wealth Management held 2,213 shares of Johnson & Johnson worth $393K as of Q2 2022.
  • BT Wealth Management sold 262 Johnson & Johnson shares in Q2 2022, an estimated $46.7K.
  • Johnson & Johnson made up 0.11% of BT Wealth Management's portfolio in Q2 2022, its #46 holding.
  • BT Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 15 quarters since.
  • BT Wealth Management's Johnson & Johnson position peaked at $2.04M in Q1 2021.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on BT Wealth Management's 13F filing for Q2 2022, filed 15 Jul 2022.